Table 3. Aranesp dose and haemoglobin response in spite of persistence of EPO antibodies and without the need of blood transfusions

Date08/11/0103/01/0218/02/0219/06/0222/07/0223/08/0216/10/02
Aranesp mcg/wk40404040202030
Hb g/dl9.410.79.714.315.214.413.1
EPO antibodiespositivepositivepositive
TransfusionYesNoNoNoNoNoNo